Classifying types of disseminated intravascular coagulation: Clinical and animal models

Journal of Intensive Care

Volumn 2, Issue 1, 2014, Pages

  Asakura, Hidesaku ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

DIC with balanced fibrinolysis; DIC with enhanced fibrinolysis; DIC with suppressed fibrinolysis; Disseminated intravascular coagulation; Tranexamic acid

Indexed keywords

LIPOPOLYSACCHARIDE;

BLOOD CLOTTING; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING WITH BALANCED FIBRINOLYSIS; DISSEMINATED INTRAVASCULAR CLOTTING WITH ENHANCED FIBRINOLYSIS; DISSEMINATED INTRAVASCULAR CLOTTING WITH SUPPRESSED FIBRINOLYSIS; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; SEPSIS;

EID: 84988732046     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/2052-0492-2-20     Document Type: Review

References (36)

1. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592
2. Gando S: The utility of a diagnostic scoring system for disseminated intravascular coagulation. Crit Care Clin 2012, 28:373-388
3. Wada H, Asakura H, Okamoto K, Iba T, Uchiyama T, Kawasugi K, Koga S, Mayumi T, Koike K, Gando S, Kushimoto S, Seki Y, Madoiwa S, Maruyama I, Yoshioka A, Japanese Society of Thrombosis Hemostasis/DIC Subcommittee: Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res 2010, 125:6-11
4. Gando S: Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010, 38(Suppl 2):S35-S42
5. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH): Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330
6. Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Nakao S: An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med 2001, 29:1164-1168
7. Matsuda T: Clinical aspects of DIC-disseminated intravascular coagulation. Pol J Pharmacol 1996, 48:73-75
8. Franchini M, Di Minno MN, Coppola A: Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost 2010, 36:388-403
9. Pawlinski R, Mackman N: Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004, 32:S293-S297
10. Pawlinski R, Pedersen B, Schabbauer G, Tencati M, Holscher T, Boisvert W, Andrade-Gordon P, Frank RD, Mackman N: Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004, 103:1342-1347
11. van der Poll T, Levi M: Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol 2012, 10:632-638
12. Egorina EM, Sovershaev MA, Hansen JB: The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrinolysis 2011, 22:451-456
13. Asakura H, Takahashi Y, Kubo A, Ontachi Y, Hayashi T, Omote M, Arahata M, Kadohira Y, Maekawa M, Yamazaki M, Morishita E, Takami A, Yoshida T, Miyamoto K, Nakao S: Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in LPS-induced DIC in rats. Crit Care Med 2006, 34:2421-2425
14. Ontachi Y, Asakura H, Takahashi Y, Hayashi T, Arahata M, Kadohira Y, Maekawa M, Omote M, Yoshida T, Yamazaki M, Morishita E, Miyamoto K, Nakao S: No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats. Crit Care Med 2006, 34:2646-2650
15. Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A: Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 1990, 33:90-95
16. Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Matsuda T: Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coagul Fibrinolysis 1994, 5:829-832
17. Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T: Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation. Am J Hematol 1991, 36:176-183
18. Yamamoto K, Ito H, Hiraiwa T, Tanaka K: Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection. Ann Thorac Surg 2009, 88:1331-1333
19. Takahashi T, Suzukawa M, Akiyama M, Hatao K, Nakamura Y: Systemic AL amyloidosis with disseminated intravascular coagulation associated with hyperfibrinolysis. Int J Hematol 2008, 87(4):371-374
20. Ontachi Y, Asakura H, Arahata M, Kadohira Y, Maekawa M, Hayashi T, Yamazaki M, Morishita E, Saito M, Minami S, Nakao S: Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. Circ J 2005, 69:1150-1153
21. Koseki M, Asada N, Uryu H, Takeuchi M, Asakura H, Matsue K: Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. Int J Hematol 2007, 86:403-406
22. Ker K, Edwards P, Perel P, Shakur H, Roberts I: Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012, 344:e3054
23. Gando S, Sawamura A, Hayakawa M: Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg 2011, 254:10-19
24. Gando S, Wada H, Thachil J, Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis (ISTH): Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Haemost 2013, 11:826-835
25. Asakura H, Suga Y, Yoshida T, Ontachi Y, Mizutani T, Kato M, Ito T, Morishita E, Yamazaki M, Miyamoto K, Nakao S: Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis 2003, 14:221-228
26. Hayakawa M, Gando S, Ieko M, Honma Y, Homma T, Yanagida Y, Kubota N, Uegaki S, Sawamura A, Asakura H: Massive amounts of tissue factor induce fibrinogenolysis without tissue hypoperfusion in rats. Shock 2013, 39:514-519
27. Asakura H, Sano Y, Yoshida T, Omote M, Ontachi Y, Mizutani T, Yamazaki M, Morishita E, Takami A, Miyamoto K, Nakao S: Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid. Intensive Care Med 2004, 30:1950-1955
28. Asakura H, Sano Y, Yamazaki M, Morishita E, Miyamoto K, Nakao S: Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats-an effect of tranexamic acid. Haematologica 2004, 89:757-758
29. Asakura H, Asamura R, Ontachi Y, Hayashi T, Omote M, Arahata M, Kadohira Y, Maekawa M, Yamazaki M, Morishita E, Yoshida T, Miyamoto K, Nakao S:Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels. Thromb Haemost 2005, 93:724-728
30. Milne AA, Drummond GB, Paterson DA, Murphy WG, Ruckley CV: Disseminated intravascular coagulation after aortic aneurysm repair, intraoperative salvage autotransfusion, and aprotinin. Lancet 1994, 344(8920):470-471
31. Naeye RL: Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocapproic acid. Blood 1962, 19:694-701
32. Charytan C, Purtilo D: Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 1969, 280(20):1102-1104
33. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA: Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1999, 340:994-1004
34. Hashimoto S, Koike T, Tatewaki W, Seki Y, Sato N, Azegami T, Tsukada N, Takahashi H, Kimura H, Ueno M: Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 1994, 8:1113-1115
35. Brown JE, Olujohungbe A, Chang J, Ryder WD, Morganstern GR, Chopra R, Scarffe JH: All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia. Br J Haematol 2000, 110:1010-1012
36. Levin MD, Betjes MG, V d Kwast TH, Wenberg BL, Leebeek FW: Acute renal cortex necrosis caused by arterial thrombosis during treatment for acute promyelocytic leukemia. Haematologica 2003, 88:ECR21